Home › Cardiovascular Disease › Washington
Cardiovascular Disease clinical trials in Washington
15 studies for Cardiovascular Disease are looking for participants at sites in Washington.
Cities in Washington
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- MultiCare Institute for Research and Innovation, Puyallup
- MultiCare Institute for Research and Innovation, Tacoma
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
- Eastside Research Associates, Redmond
RecruitingPhase 3
Ages 45 to 80 · All sexes · Updated Sep 22, 2026 · NCT07613294Product Surveillance Registry
- Bremerton
- Seattle
- Spokane
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Bellevue
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07181109EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Universal Research Group, LLC, Tacoma
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07064473Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- University of Washington (UW) Medical Center, Seattle
- Providence Sacred Heart Medical Center & Children's Hospital, Spokane
Recruiting
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT03242642An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Harborview Medical Center, Seattle
- Swedish Medical Center-Cardiovascular Research, Seattle
- Univ of Washington Medical Center, Seattle
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 4, 2026 · NCT07517263A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
- Seattle Children's Hospital, Seattle
RecruitingObservational study
Ages 7 and older · All sexes · Updated Aug 25, 2026 · NCT05705531A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Puyallup
- Research Site, Redmond
- Research Site, Renton
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Western Washington Medical Group, Everett
- Rainier Clinical Research Center, Renton
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012Global Paradise System US Post Approval Study
- Swedish Medical Center, Seattle
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT06297291ELEVATE-HFpEF Clinical Study
- Saint Joseph Medical Center (Tacoma WA), Tacoma
Recruiting
Ages 40 and older · All sexes · Updated Aug 3, 2026 · NCT06678841PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Providence Everett, Everett
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05934487Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Mar 24, 2026 · NCT06217302MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
- Seattle Children's Hospital, Seattle
RecruitingPhase 1
Ages 12 to 25 · All sexes · Updated Jun 13, 2025 · NCT05065372From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.